CP
DPLO

Corbenic Partners’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Corbenic Partners’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,000
Closed -$8K – 226
2019
Q4 		$8K Buy
+2,000
New +$9.39K 0.01% 131

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Corbenic Partners's DPLO Position: Q1 2020 in Review

Corbenic Partners sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 2,000 shares — an estimated $8K sold.

Corbenic Partners first reported a position in DPLO in Q4 2019 and held it in 1 quarter. The position peaked at $8K in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Corbenic Partners reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Corbenic Partners sold 2,000 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $8K.
  • Corbenic Partners first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2019 and held it in 1 quarter.
  • Corbenic Partners's DIPLOMAT PHARMACY, INC. position peaked at $8K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Corbenic Partners's 13F filing for Q1 2020, filed 16 Apr 2020.